8SE6
NKG2D complexed with inhibitor 36
Summary for 8SE6
Entry DOI | 10.2210/pdb8se6/pdb |
Descriptor | NKG2-D type II integral membrane protein, TRIETHYLENE GLYCOL, N-[(1S)-2-(dimethylamino)-2-oxo-1-{3-[3-(2,2,2-trifluoroethyl)azetidin-1-yl]phenyl}ethyl]-4'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxamide, ... (5 entities in total) |
Functional Keywords | nkg2d, del, cryptic pocket, immunoreceptors, immune system, signaling protein, immune system-inhibitor complex, immune system/inhibitor |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 2 |
Total formula weight | 31120.12 |
Authors | Thompson, A.A.,Grant, J.C.,Karpowich, N.K.,Sharma, S. (deposition date: 2023-04-08, release date: 2023-10-11, Last modification date: 2023-11-01) |
Primary citation | Wang, J.,Nakafuku, K.M.,Ziff, J.,Gelin, C.F.,Gholami, H.,Thompson, A.A.,Karpowich, N.K.,Limon, L.,Coate, H.R.,Damm-Ganamet, K.L.,Shih, A.Y.,Grant, J.C.,Cote, M.,Mak, P.A.,Pascual, H.A.,Rives, M.L.,Edwards, J.P.,Venable, J.D.,Venkatesan, H.,Shi, Z.,Allen, S.J.,Sharma, S.,Kung, P.P.,Shireman, B.T. Development of small molecule inhibitors of natural killer group 2D receptor (NKG2D). Bioorg.Med.Chem.Lett., 96:129492-129492, 2023 Cited by PubMed: 37778428DOI: 10.1016/j.bmcl.2023.129492 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.36 Å) |
Structure validation
Download full validation report